Knie Robb

Knie Robb is listed in filings as CEO and President at Hoth Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 28, 2026, including purchase activity. Recent filings connect the profile to Hoth Therapeutics, Inc. (RKTO). The current snapshot covers public activity from Aug 19, 2024 to May 28, 2026. Reported amounts are shown as $389.6K to $144.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.